Assessing the Accuracy of Cardiovascular Disease Prediction Using Female-Specific Risk Factors in Women Aged 45 to 69

Jenny Doust1, Mohammad Reza Baneshi1, Hsin-Fang Chung1

  • 1Australian Women and Girls' Health Research Centre, School of Public Health, The University of Queensland, Herston, Australia.

Insights

Adding female-specific risk factors to traditional cardiovascular disease (CVD) prediction models did not significantly improve risk reclassification in women aged 45-69. These factors should not be used for medication decisions in this age group.

Area of Science:

  • Cardiology
  • Epidemiology
  • Women's Health

Background:

  • Cardiovascular disease (CVD) is the primary cause of mortality among women.
  • Traditional risk calculators may not fully capture CVD risk in women.
  • Investigating female-specific factors is crucial for accurate risk prediction.

Purpose of the Study:

  • To evaluate if incorporating female-specific risk factors enhances CVD risk prediction in women.
  • To assess the impact of these factors on discrimination and calibration of existing risk models.

Main Methods:

  • Utilized UK Biobank data from women aged 45-69, free of CVD at baseline.
  • Employed Cox proportional hazards models with traditional risk factors from three calculators (PCE-ASCVD, Qrisk2, PREDICT).
  • Added female-specific factors (e.g., menarche, endometriosis, menopause, pregnancy history) individually and combined to assess predictive improvements.

Main Results:

  • The addition of individual female-specific risk factors did not improve model discrimination or calibration (c-indices ranged from 0.710 to 0.718).
  • Simultaneously adding all female-specific factors resulted in a minor increase in c-indices (up to 0.720).
  • No significant improvement in reclassification metrics or calibration plots was observed.

Conclusions:

  • While some female-specific factors indicate early CVD risk, they do not improve risk reclassification in women aged 45-69 for medication initiation.
  • Current traditional risk calculators, when augmented with these factors, do not offer substantial gains for clinical decision-making in this demographic.
  • Further research may be needed to identify other factors or refine existing ones for better CVD risk prediction in women.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
278
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
3
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
57
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
25
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
120
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
3.0K